Advertisement
U.S. markets closed
Advertisement

Nouveau Life Pharmaceuticals, Inc. (NOUV)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00020.0000 (0.00%)
At close: 03:48PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0002
Open0.0001
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0001 - 0.0003
52 Week Range0.0001 - 0.0004
Volume40,340,372
Avg. Volume6,093,823
Market Cap969,597
Beta (5Y Monthly)-3.80
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NOUV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NOUVEAU LIFE PHARMACEUTICALS IN
    Analyst Report: Donaldson Company, Inc.Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.4 billion in revenue and $480 million in operating income in its fiscal 2023.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.